Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma

This case-control study assesses the association of hydrochlorothiazide with risk of malignant melanoma among Danish adults.

[1]  M. Volpe,et al.  Recent Warnings about Antihypertensive Drugs and Cancer Risk: Where Do They Come From? , 2019, European cardiology.

[2]  P. Chowienczyk,et al.  A review of the prescribing trend of thiazide‐type and thiazide‐like diuretics in hypertension: A UK perspective , 2019, British journal of clinical pharmacology.

[3]  A. Pottegård,et al.  Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study , 2019, British Journal of Cancer.

[4]  D. Palli,et al.  Do Thiazide Diuretics Increase the Risk of Skin Cancer? A Critical Review of the Scientific Evidence and Updated Meta-Analysis , 2019, Current Cardiology Reports.

[5]  A. Pottegård,et al.  Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case‐control study from Denmark , 2017, Journal of the American Academy of Dermatology.

[6]  J. Hallas,et al.  Hydrochlorothiazide use is strongly associated with risk of lip cancer , 2017, Journal of internal medicine.

[7]  S. Lemeshow,et al.  Use of antihypertensive drugs and risk of skin cancer , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  Henrik Toft Sørensen,et al.  The Danish Civil Registration System as a tool in epidemiology , 2014, European Journal of Epidemiology.

[9]  H. Sørensen,et al.  Use of photosensitising diuretics and risk of skin cancer: a population-based case–control study , 2008, British Journal of Cancer.

[10]  D. Whiteman,et al.  Anatomic site, sun exposure, and risk of cutaneous melanoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.